• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CLARE DISCRETE MFG IO ACCESS SARS-COV-2 IGG; IN VITRO DIAGNOSTIC DEVICES: CORONAVIRUS SEROLOGICAL REAGENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CLARE DISCRETE MFG IO ACCESS SARS-COV-2 IGG; IN VITRO DIAGNOSTIC DEVICES: CORONAVIRUS SEROLOGICAL REAGENTS Back to Search Results
Catalog Number C58961
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/12/2020
Event Type  malfunction  
Manufacturer Narrative
Patient identifier: the fill patient identifier is case-(b)(6).Repeatable non-reactive sars-cov-2 igg results were reported for three patients on (b)(6) 2020.Age or date of birth, sex, weight and ethnicity: the customer did not supply patient demographics such as age, date of birth, sex, weight, ethnicity or race.Device evaluated by mfr: the access sars-cov-2 igg reagent was not returned for evaluation.No hardware errors or other assay issues were reported in conjunction with this event.Field service engineer (fse) performed some verification tests.Low volume pipettor matching passed on (b)(6).The instrument is working within specifications.Further comparisons were performed with samples across different methodologies with different results and interpretations.No manufacturer guarantees both a specificity and sensitivity of 100%.Differences in each individual assay are expected.The roche and architect assays detects antibodies directed against the nucleocapsid of the virus while the access and ichroma covid-19 ab assays detect antibodies directed against the spike protein, which are more likely to neutralize the virus.The roche and the ichroma covid-19 ab assays are total assays.They detect igm, igg and iga without distinction; therefore, the results are not comparable.In conclusion, the exact cause of this event cannot be determined with the available information.Differences between methods are expected.There is no evidence to reasonably suggest that a malfunction occurred in conjunction with this event.
 
Event Description
On (b)(6) 2020 the customer reported repeatable non-reactive sars-cov-2 igg (access sars-cov-2 igg assay, part number c58961, lot number 971195) results were generated on the customer's dxi 800 immunoassay analyzer (part number 973100 and serial number (b)(4).On (b)(6) 2020, repeatable non-reactive access sars-cov-2 igg results were obtained for three patients.The access results were discordant with the roche sars-cov-2 ab, the i-chroma ab boditech med sars-cov-2 igg and the abbott architect sars-cov-2 igg.Positive pcr were provided for the three patients.No affect to patients or end-users has been reported in connection with this event.The customer indicated the results were not released outside the laboratory.No hardware errors or issues with other assays were reported in conjunction with this event.Calibration passed on 6nov2020.Quality control (qc) was passing within the laboratorys established ranges.No system check data was provided.There were no issues with sample integrity reported by the customer.Sample collection, handling and processing information such as sample type, sample volume collected, centrifugation, storage and other sample related information was not provided by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCESS SARS-COV-2 IGG
Type of Device
IN VITRO DIAGNOSTIC DEVICES: CORONAVIRUS SEROLOGICAL REAGENTS
Manufacturer (Section D)
CLARE DISCRETE MFG IO
lismeehan
o'callaghans mills
EI 
Manufacturer (Section G)
CLARE DISCRETE MFG IO
lismeehan
o'callaghans mills
EI  
Manufacturer Contact
harry long
1000 lake hazeltine drive
chaska, MN 
9523681224
MDR Report Key10992648
MDR Text Key253307195
Report Number9680746-2020-00051
Device Sequence Number1
Product Code QKO
UDI-Device Identifier15099590738648
UDI-Public(01)15099590738648(17)201224(11)200428(10)971195
Combination Product (y/n)N
Reporter Country CodeBR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/11/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/24/2020
Device Catalogue NumberC58961
Device Lot Number971195
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date11/13/2020
Date Manufacturer Received11/13/2020
Was Device Evaluated by Manufacturer? No
Date Device Manufactured04/28/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-